dc.contributor.author | Mateos, María Victoria | |
dc.contributor.author | Weisel, Katja | |
dc.contributor.author | Terpos, Evangelos | |
dc.contributor.author | Delimpasi, Sossana | |
dc.contributor.author | Kastritis, Efstathios | |
dc.contributor.author | Zamagni, Elena | |
dc.contributor.author | Delforge, Michel | |
dc.contributor.author | Ocio San Miguel, Enrique María | |
dc.contributor.author | Katodritou, Eirini | |
dc.contributor.author | Gay, Francesca | |
dc.contributor.author | Larocca, Alessandra | |
dc.contributor.author | Leleu, Xavier | |
dc.contributor.author | Rodríguez Otero, Paula | |
dc.contributor.author | Schjesvold, Fredik | |
dc.contributor.author | Cavo, Michele | |
dc.contributor.author | Dimopoulos, Meletios A. | |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2024-10-28T18:47:34Z | |
dc.date.available | 2024-10-28T18:47:34Z | |
dc.date.issued | 2024 | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.issn | 1592-8721 | |
dc.identifier.uri | https://hdl.handle.net/10902/34367 | |
dc.format.extent | 4 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Ferrata Storti Foundation | es_ES |
dc.rights | ©2024 Ferrata Storti Foundation. Published under a CC BY-NC license. | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.source | Haematologica, 2024, 109(7), 2337-2340 | es_ES |
dc.title | Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://doi.org/10.3324/haematol.2023.284694 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.3324/haematol.2023.284694 | |
dc.type.version | publishedVersion | es_ES |